Literature DB >> 27122827

Soluble ST2: A Novel Prognostic Biomarker of Heart Failure.

Ying-Chang Tung1, Pao-Hsien Chu2.   

Abstract

Entities:  

Year:  2014        PMID： 27122827      PMCID： PMC4834966     

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  22 in total

1.  Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Gilles W De Keulenaer; Catherine MacGillivray; Shin-ichi Tominaga; Scott D Solomon; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure.

Authors:  Antoni Bayes-Genis; Domingo Pascual-Figal; James L Januzzi; Alan Maisel; Teresa Casas; Mariano Valdés Chávarri; Jordi Ordóñez-Llanos
Journal:  Rev Esp Cardiol       Date:  2010-10       Impact factor: 4.753

3.  ST2 protein in heart disease: from discovery to mechanisms and prognostic value.

Authors:  Ellen O Weinberg
Journal:  Biomark Med       Date:  2009-10       Impact factor: 2.851

4.  Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.

Authors:  Ravi V Shah; Annabel A Chen-Tournoux; Michael H Picard; Roland R J van Kimmenade; James L Januzzi
Journal:  Circ Heart Fail       Date:  2009-05-14       Impact factor: 8.790

5.  High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kristin McCloskey; J Eduardo Rame; Erin McIntosh; Puja Shahi; Daniel L Dries; W H Wilson Tang; Alan H B Wu; James C Fang; Rebecca Boxer; Nancy K Sweitzer; Wayne C Levy; Lee R Goldberg; Mariell Jessup; Thomas P Cappola
Journal:  Circ Heart Fail       Date:  2010-12-22       Impact factor: 8.790

Review 6.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

7.  Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.

Authors:  Shafiq U Rehman; Thomas Mueller; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2008-10-28       Impact factor: 24.094

8.  Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.

Authors:  Thomas Mueller; Benjamin Dieplinger; Alfons Gegenhuber; Werner Poelz; Richard Pacher; Meinhard Haltmayer
Journal:  Clin Chem       Date:  2008-04       Impact factor: 8.327

9.  Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).

Authors:  Josep Lupón; Marta de Antonio; Joan Vila; Judith Peñafiel; Amparo Galán; Elisabet Zamora; Agustín Urrutia; Antoni Bayes-Genis
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

10.  Soluble ST2 protein in chronic heart failure is independent of traditional factors.

Authors:  Karolina Wojtczak-Soska; Tadeusz Pietrucha; Agata Sakowicz; Malgorzata Lelonek
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318
View more
  4 in total

1.  Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.

Authors:  Isabel M Billiar; Jesse Guardado; Othman Abdul-Malak; Yoram Vodovotz; Timothy R Billiar; Rami A Namas
Journal:  J Surg Res       Date:  2019-07-03       Impact factor: 2.192

2.  Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction.

Authors:  Ying-Chang Tung; Chih-Hsiang Chang; Yung-Chang Chen; Pao-Hsien Chu
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

3.  IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.

Authors:  Ozkan Gungor; Hilmi Umut Unal; Aydin Guclu; Mustafa Gezer; Tayfun Eyileten; Fatma Betül Guzel; Orcun Altunoren; Ertugrul Erken; Yusuf Oguz; Ismail Kocyigit; Mahmut Ilker Yilmaz
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

4.  Betuletol, a Propolis Component, Suppresses IL-33 Gene Expression and Effective against Eosinophilia.

Authors:  Aurpita Shaha; Rezwanul Islam; Naonobu Tanaka; Yoshiki Kashiwada; Hiroyuki Fukui; Noriaki Takeda; Yoshiaki Kitamura; Hiroyuki Mizuguchi
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.